Amy P. Abernethy, M.D., Duke University Schools of Medicine and Nursing and Duke Comprehensive Cancer Center
Amy P. Abernethy, M.D., is a tenured Associate Professor in Duke University Schools of Medicine and Nursing, Director of the Duke Cancer Care Research Program, and a medical oncologist and palliative medicine physician. She is an appointee to the Institute of Medicine’s National Cancer Policy Forum, President-Elect of the American Academy of Hospice and Palliative Medicine, on the Board of Directors for the Personalized Medicine Coalition, on the Advisory Board for the Rapid Learning System for Cancer for the American Society of Clinical Oncology and Co-Chair of the National Institutes of Health-funded Palliative Care Research Cooperative Group. Dr. Abernethy participates integrally in international discussions about reforming the evidence development system, presenting a model for rapid learning healthcare by coordinating clinical and research functions to better serve patients’ needs in an evidence-driven, cost-effective and patient-centered manner.
Dr. Abernethy is an internationally recognized expert in health services research and delivery in patient-centered cancer care. She directs a prolific research program, Duke Cancer Care Research Program, which conducts patient-centered clinical trials, analyses, and policy studies. Duke Cancer Care Research Program maintains a large portfolio of National Institutes of Health (NIH), National Cancer Institute (NCI), Agency for Healthcare Research and Quality (AHRQ), philanthropic, and private funding. All studies make use of, and simultaneously contribute to the development of, an integrated data system that coordinates diverse datasets, leverages novel information technology for patient reporting of symptoms and other concerns, informs future studies, and facilitates patient education and patient-provider communication. Dr. Abernethy is Co-Principal Investigator of the NIH-funded Palliative Care Research Cooperative Group and Co-Principal Investigator of a NCI-funded faculty development (K01) program in comparative effectiveness research to develop the research workforce of the future.
The Age of Personalized Medicine Blog 